pathogenet
link
viral
infect
renal
diseas
often
difficult
establish
criteria
prove
causal
complex
includ
besid
recognit
clinic
syndrom
serolog
diagnosi
identif
specif
viral
antigenemia
detect
glomerular
structur
viral
antigen
host
antibodi
accord
koch
postul
etiolog
link
confirm
complet
cure
follow
erad
viru
alway
possibl
concentr
viral
antigen
higher
tissu
circul
antigen
complex
specif
autoantibodi
virolog
molecular
anali
si
patholog
tissu
situ
hybridiza
tion
polymeras
chain
reaction
ultra
structur
analysi
led
success
detect
identifica
tion
viru
note
tubular
uptak
viral
particl
common
necessarili
establish
etiolog
link
renal
diseas
improv
renal
diseas
concomit
clearanc
suspect
antigen
recurr
glomerulonephr
follow
reinfect
addit
clinic
criteria
differ
mechan
oper
differ
viral
nephropathi
box
acut
glomerulonephr
direct
viral
infect
glomerulu
induc
prolif
chang
follow
releas
cytokin
nephropathi
revers
case
viru
rapidli
clear
chronic
form
glomerulonephr
persist
viral
infect
provid
continu
antigen
stimul
result
antibodi
product
format
immun
complex
studi
indic
role
diseas
pathogenesi
immun
complex
deriv
circul
form
situ
viral
protein
caus
inflammatori
renal
diseas
via
synthesi
variou
mediat
caus
sclerosi
worsen
glomerulopathi
viral
infect
caus
mani
glomerular
diseas
diagnost
criteria
virusrel
nephropathi
includ
detail
clinic
laboratori
data
tissu
molecular
analysi
sever
mechan
involv
pathogenesi
virusrel
nephropathi
includ
tropism
viru
kidney
induct
abnorm
immun
complex
direct
cytopathogen
effect
multiorgan
failur
hepat
b
viru
associ
membran
nephropathi
mesangiocapillari
glomerulonephr
endem
area
hepat
c
viru
caus
variou
form
glomerulonephr
includ
cryoglobulinemiamedi
glomerulonephr
infect
hiv
associ
collaps
focal
segment
glomerulosclerosi
distinct
diseas
affect
mainli
african
african
american
cours
hiv
infect
type
immun
complex
glomerulonephr
occur
frequent
white
recent
report
indic
role
parvoviru
idiopath
collaps
focal
segment
glomerulosclerosi
hantavirus
coronavirus
associ
sever
acut
respiratori
syndrom
lead
acut
renal
failur
renal
biopsi
follow
appropri
serolog
molecular
test
essenti
defin
virusrel
glomerular
lesion
guid
prognost
therapeut
evalu
direct
cytopath
effect
viral
protein
also
postul
hepat
c
viru
hcv
induc
mesangiocapillari
glomerulonephr
mcgn
product
circul
cryo
globulin
induc
abnorm
host
respons
infect
cryoglobulin
either
type
ii
type
iii
least
two
class
immuno
globulin
involv
one
polyclon
acut
renal
failur
associ
infect
hantaviru
sever
acut
respiratori
syndrom
coronaviru
pathogenet
mechan
interstiti
nephriti
dissemin
intravascular
coagulopathi
multiorgan
failurerath
format
immun
complexesar
predomin
box
list
virus
known
induc
renal
diseas
global
frequent
well
recogn
virusrel
glomerulonephropathi
associ
hepat
b
viru
hbv
format
immun
complex
import
hcv
etiolog
agent
cryoglobulinemiarel
mcgn
case
infect
hiv
induc
broad
spectrum
glomerular
lesion
via
multipl
pathogen
mechan
parvoviru
associ
nonhiv
collaps
glomerulopathi
idiopath
focal
segment
glomerulosclerosi
fsg
immun
complex
glomerulonephr
polyoma
bk
viru
hantaviru
frequent
caus
tubulointerstiti
damag
occasion
viru
simultan
local
glomerulu
rare
specul
role
glomerulonephritid
current
attribut
virus
caus
yellow
fever
mump
measl
varicella
herp
hbv
hepatotrop
doublestrand
dna
viru
hepadnavirida
famili
hbv
cytopath
hepat
develop
result
host
immun
reaction
infect
hepatocyt
hbv
use
revers
transcriptas
transcrib
rna
dna
unlik
retrovirus
howev
hbv
dna
integr
host
cell
dna
replic
hbv
particl
bind
enter
hepatocyt
hbv
dna
enter
cell
nucleu
convert
coval
close
circular
dna
highli
stabl
genet
materi
act
intermedi
templat
transcript
rna
copi
pregenom
messeng
rna
transport
cytoplasm
dual
function
act
templat
synthesi
new
hbv
dna
carri
genet
inform
direct
synthesi
viral
protein
today
estim
million
peopl
worldwid
infect
hbv
endem
area
transmiss
usual
verticalthat
infect
mother
child
horizont
transmiss
occur
via
direct
contact
blood
eg
blood
transfus
mucou
membran
eg
sexual
contact
via
percutan
rout
upon
contact
blood
bodi
fluid
eg
intraven
drug
use
needl
share
famili
cluster
viru
occur
region
report
preval
hbvassoci
nephropathi
close
parallel
geograph
pattern
preval
hbv
frequent
report
asian
popul
children
particularli
male
children
contrast
mesangi
prolif
form
iga
deposit
seem
common
adult
three
type
glomerulonephr
patholog
characterist
similar
human
subtyp
describ
woodchuck
chronic
infect
hepat
viru
human
membran
pattern
injuri
frequent
affect
young
woodchuck
wherea
mesangi
prolif
pattern
injuri
tend
affect
older
anim
male
femal
ratio
affect
woodchuck
significantli
greater
chronic
carrier
popul
report
diagnosi
hbvasso
ciat
glomerulonephr
base
persist
circul
hbv
hbv
dna
absenc
caus
agent
presenc
hbvspecif
antigen
viral
genom
glomerulu
one
major
differ
human
woodchuck
studi
hepat
b
e
antigen
hbeag
system
character
latter
clinic
practic
regress
patholog
follow
viral
erad
easi
demonstr
ethic
concern
relat
repeat
renal
biopsi
human
subsequ
clinic
remiss
diagnosi
hbvassoci
renal
diseas
usual
reli
heavili
upon
detect
hbvspecif
antigen
glomeruli
laboratori
test
diagnosi
assess
respons
treatment
includ
standard
liver
biochemistri
serum
alanin
aminotransferas
bilirubin
level
hbv
serolog
hepat
b
surfac
antigen
hbeag
antihepat
b
e
antihepat
b
core
antigen
antibodi
hbeag
present
patient
might
also
high
titer
antihepat
b
core
antigen
subject
biochem
hepat
test
circul
hbv
dna
undergo
liver
biopsi
assay
could
import
adjunct
serum
level
low
patient
hbvrelat
membran
nephropathi
tend
manifest
slightli
differ
pediatr
adult
patient
children
strong
male
preponder
frequent
present
nephrot
syndrom
microscop
hematuria
normal
mildli
impair
renal
function
pediatr
chronic
hbv
carrier
often
overt
liver
diseas
transaminas
level
usual
normal
adult
proteinuria
nephrot
syndrom
common
manifest
adult
male
predomin
less
obviou
pediatr
popul
adult
like
children
hypertens
renal
dysfunct
clinic
evid
liver
diseas
prognosi
hbvassoci
membran
nephropathi
children
favor
stabl
renal
function
high
rate
spontan
remiss
report
sever
geograph
area
diseas
preval
high
contrast
adult
hbvassoci
membran
nephro
pathi
typic
develop
progress
diseas
hong
kong
patient
progress
renal
failur
anoth
develop
termin
uremia
year
prognosi
even
wors
patient
nephroticrang
proteinuria
abnorm
liver
function
test
present
patient
requir
renal
replac
therapi
within
year
vertic
transmiss
associ
poorer
outcom
horizont
transmiss
endem
versu
sporad
infect
box
viral
infect
caus
nephropathi
mention
hbv
infect
also
caus
mcgn
without
cryoglobulinemia
mesangi
prolif
glomerulonephr
igan
polyarter
nodosa
report
patient
hbv
might
respond
treatment
corticosteroid
occasion
concomit
patholog
subtyp
lead
doubl
glomerulopathi
instanc
membran
nephropathi
igan
report
coexist
hbv
carrier
unlik
affect
children
high
rate
spontan
remiss
adult
hbvassoci
membran
nephropathi
typic
develop
progress
diseas
variou
manag
strategi
tri
ideal
agent
yet
found
treatment
hbvassoci
renal
diseas
ideal
achiev
follow
object
amelior
nephrot
syndrom
complic
ii
preserv
renal
function
iii
normal
liver
function
prevent
hepat
complic
hbv
iv
perman
erad
hbv
involv
immun
complex
diseas
immunosuppress
therapysimilar
use
idiopath
form
diseasewa
fashion
corticosteroid
report
provid
symptomat
relief
isol
case
contemporari
view
howev
steroid
cytotox
agent
caus
deleteri
hepat
flare
even
fatal
decompens
enhanc
viral
replic
drug
withdrawn
anoth
approach
treatment
antivir
agent
natur
occur
cytokin
produc
b
lymphocyt
null
lymphocyt
macrophag
exert
antivir
antiprolif
immuno
modulatori
effect
reportedli
use
children
produc
mix
result
adult
hbvassoci
membran
nephropathi
introduct
nucleosid
analog
lamivudin
revolution
treatment
chronic
hbv
infect
lamivudin
enantiom
analog
inhibit
dna
synthesi
termin
nascent
provir
dna
chain
inter
ferenc
revers
transcriptas
activ
hbv
children
adult
hbvasso
ciat
membran
nephropathi
lamivudin
anecdot
report
induc
remiss
nephrot
syndrom
suppress
viral
replic
recent
analysi
compar
adult
nephrot
patient
hbvrelat
membran
nephropathi
receiv
lamivudin
match
histor
control
subject
present
prelamivudin
era
lamivudin
significantli
improv
proteinuria
aminotransferas
level
renal
outcom
period
random
studi
larger
cohort
patient
need
prove
effect
potenti
limit
prolong
treatment
lamivudin
emerg
drugresist
viru
strain
result
induct
select
hbv
variant
mutat
tyrosinemethionineaspartateaspart
ymdd
motif
dna
polymeras
one
agent
might
use
lamivudineresist
case
adefovir
dipivoxil
acycl
nucleotid
analog
effect
lamivudineresist
hbv
mutant
wildtyp
hbv
agent
nephrotox
potenti
clinic
data
efficaci
hbvrelat
membran
nephro
pathi
respond
lamivudin
treatment
data
indic
howev
recommend
dose
mg
adefovir
dipivoxil
associ
rel
low
risk
nephro
toxic
await
ideal
agent
treatment
hbvassoci
glomerulopathi
activ
immuniza
tion
remain
effect
mean
immunoprophylaxi
taiwan
activ
immun
newborn
sinc
led
dramat
declin
incid
neonat
hbv
infect
sequela
us
univers
vaccin
infant
began
reduct
hbv
infect
record
year
later
recommend
countri
establish
univers
hbv
immun
program
infant
adolesc
hcv
small
rna
viru
flavivirida
famili
evolut
hcv
character
emerg
six
major
genotyp
base
sequenc
homolog
subtyp
date
around
million
individu
worldwid
estim
chronic
infect
hcv
although
viral
replic
primarili
confin
liver
varieti
extrahepat
diseas
manifest
associ
hcv
infect
princip
renal
manifest
hcv
infect
mcgn
type
usual
context
type
ii
mix
cryoglobulinemia
preval
mcgn
hcv
type
ii
cryoglobulinemia
approxim
mcgn
occasion
observ
patient
hepat
c
absenc
cryoglobulinemia
type
ii
mcgn
eg
dens
deposit
diseas
describ
associ
hcv
infect
two
immunolog
featur
hcv
might
underli
predisposit
extrahepat
diseas
manifest
first
hcv
known
evad
immun
elimin
lead
chronic
infect
accumul
circul
immun
complex
mcgn
associ
hcv
infect
might
result
phenomenon
second
hcv
stimul
product
monoclon
rheumatoid
factor
featur
caus
type
ii
cryoglobulinemia
account
symptomat
cryoglobulinem
vascul
although
manifest
occur
rel
infrequ
extrahepat
diseas
manifest
account
much
increas
morbid
mortal
accompani
diseas
hcvinfect
patient
report
mix
cryoglobulinemia
preval
increas
durat
hepat
note
howev
preval
mix
cryo
globulinemia
determin
popula
tion
unselect
hcvinfect
patient
frank
symptomat
cryoglobulinemia
affect
less
patient
usual
associ
high
level
rheumatoid
factor
cryo
globulin
test
unselect
patient
cryo
globulinemia
shown
antihcv
antibodi
type
mcgn
long
regard
idiopath
consid
abl
proport
patient
concomit
chronic
hcv
infect
exact
proport
patient
type
mcgn
antihcvantibodyposit
unknown
true
preval
mcgn
without
detect
cryoglobulinemia
difficult
assess
case
might
repres
subclin
form
cryoglobulinemia
circul
cryoglobulin
detect
standard
laboratori
techniqu
product
igm
antibodi
antiigg
activ
might
induc
format
immun
complex
lack
cryoprecipit
properti
final
patient
might
develop
detect
circul
cryoglobulinemia
later
cours
diseas
laboratori
test
coupl
renal
biopsi
establish
diagnosi
hcvrelat
mcgn
patient
antihcv
antibodi
well
hcv
rna
serum
serum
transaminas
level
elev
patient
cryoglobulin
detect
patient
serum
electrophoresi
immunofix
detect
type
ii
mix
cryo
globulin
monoclon
rheumatoid
factor
almost
variabl
distinguish
featur
cryo
globulinem
glomerulonephr
amount
cryoglobulin
usual
measur
cryocrit
vari
patient
time
given
patient
rang
light
chain
also
commonli
present
urin
serum
complement
pattern
chang
greatli
clinic
diseas
activ
also
discrimin
characterist
earli
complement
compon
present
low
undetect
level
patient
wherea
level
tend
remain
normal
slightli
depress
renal
diseas
associ
hcv
rare
children
typic
age
diseas
onset
fifth
sixth
decad
life
longstand
infect
often
associ
mild
subclin
liver
diseas
patient
might
symptom
cryoglobulinemia
palpabl
purpura
arthralgia
renal
manifest
includ
nephrot
nonnephrot
proteinuria
microscop
hematuria
acut
nephrit
syndrom
present
featur
quarter
case
renal
insuffici
frequent
mild
sever
occur
half
patient
patient
refractori
hypertens
present
might
respons
consider
number
cardiovascular
death
clinic
cours
hcvassoci
renal
diseas
vari
dramat
diseas
frequent
progress
uremia
despit
persist
urinari
abnorm
major
patient
progress
occur
tend
male
older
age
accord
italian
seri
around
patient
eventu
requir
dialysi
form
glomerular
injuri
includ
membran
nephropathi
fsg
mesangi
prolif
glomerulonephr
crescent
glomerulonephr
report
hcv
carrier
individu
case
report
small
seri
notabl
membran
nephropathi
hcv
carrier
character
absenc
cryoglobulin
male
predomin
gener
therapi
direct
two
level
remov
cryoglobulin
plasmapheresi
inhibit
cryoglobulin
synthesi
attenu
immun
respons
use
steroid
cytotox
agent
suppress
viral
replic
use
interferon
ribavirin
associ
hcv
cryo
globulinem
mcgn
establish
steroid
cyclophosphamid
mainstay
treatment
awar
link
facilit
ration
approach
manag
condit
control
trial
shown
antivir
therapi
asso
ciat
improv
system
symptom
immun
complex
diseas
unfortun
posttherapi
relaps
occur
larg
pro
portion
patient
particularli
interferon
monotherapi
administ
short
cours
introduct
combin
therapi
plu
ribavirin
import
mileston
treatment
chronic
hepat
c
cocktail
also
produc
favor
result
mix
cryo
globulinemia
although
nonrespons
relaps
initi
improv
still
occur
introduct
pegyl
form
interferon
peginterferon
anoth
breakthrough
treatment
chronic
hepat
c
recent
data
peginterferon
ribavirin
combin
therapi
encourag
increas
rate
treatment
failur
carrier
hcv
genotyp
recogn
observ
studi
support
effect
peginterferon
ribavirin
combin
therapi
hcvassoci
cryoglobulinem
mcgn
one
therapeut
drawback
hemolyt
effect
complic
ribavirin
therapi
particularli
patient
function
renal
impair
difficulti
overcom
adjust
dose
accord
glomerular
filtrat
rate
instead
bodi
weight
alon
util
recombin
erythropoietin
combat
anemia
posttreat
renal
biopsi
show
histolog
improv
two
three
patient
receiv
combin
therapi
month
wide
spectrum
glomerulopathi
occur
cours
hiv
infect
classifi
four
group
first
group
classic
hivassoci
nephropathi
hivan
distinct
entiti
histolog
featur
fsg
tuft
collaps
rare
mesangi
hyperplasia
hivan
seem
relat
direct
effect
hiv
viral
protein
renal
epithelium
second
group
diffus
proliferativemesangiocapillari
lupuslik
glomerulonephr
predominantli
mesangi
immun
deposit
also
known
hiv
immunecomplexmedi
diseas
group
also
includ
immunecomplexmedi
glomerulonephritid
moreheterogen
histolog
featur
third
group
includ
immunotactoid
glomerulonephr
heterogen
regard
glomerular
lesion
pathogen
mechan
still
undefin
true
role
hiv
infect
glomerulopathi
type
also
uncertain
final
group
includ
hivassoci
thrombot
microangiopathyhemolyt
urem
syndrom
hiv
main
sole
etiolog
factor
ethnicgeograph
background
import
determin
type
glomerulopathi
associ
hiv
exampl
collaps
fsg
preval
patient
african
descent
fsg
variant
hivan
commonli
report
chronic
renal
diseas
associ
hiv
infect
hivan
affect
hivinfect
patient
african
descentmainli
male
risk
drug
abus
often
african
american
glomerular
chang
associ
variant
capillari
wall
collaps
vari
sever
widen
bowman
space
viscer
epi
thelial
cell
undergo
hyperplasia
hypertrophi
develop
protein
inclus
swollen
cytoplasm
surround
collaps
lobul
sclerosi
affect
segment
capillari
tuft
whole
glomerular
surfac
tubular
cell
might
undergo
degen
chang
necrosi
flatten
larg
dens
cast
develop
dilat
tubul
detect
hiv
rna
renal
tissu
patient
hivan
hiv
dna
patient
without
nephropathi
rais
question
whether
renal
cell
infect
vivo
tubular
epitheli
cell
infect
vitro
renal
uptak
viral
gene
product
might
induc
transactiv
host
lai
lai
may
vol
wwwnaturecomclinicalpracticeneph
gene
renal
cell
hiv
protein
caus
apoptosi
phenotyp
modif
subsequ
tubulointerstiti
fibrosi
clinic
manifest
hivan
fsg
nephroticrang
proteinuria
renal
insuffici
hypertens
edema
uncommon
overt
case
ultrasonographi
typic
reveal
enlarg
highli
echogen
kidney
probabl
develop
respons
microcyst
tubular
dilat
effect
antiretrovir
treatment
avail
clinic
progress
rapid
intens
antiretrovir
treatment
delay
progress
patholog
hivassoci
diseas
mediat
immun
complex
resembl
lupu
nephropathi
clinic
present
nephrot
syndrom
microscop
hematuria
progress
renal
failur
occur
slowli
hivan
patient
often
hcv
coinfect
hiv
seem
prevail
role
viral
antigen
detect
glomeruli
antibodi
elut
kidney
react
hiv
antigen
circul
immun
complex
antigen
case
hivrel
igan
circul
immun
complex
contain
iga
idiotyp
antibodi
detect
patient
hivassoci
thrombot
microangiopathyhemolyt
urem
syndrom
present
acut
renal
failur
microscop
hematuria
nonnephrot
proteinuria
multiorgan
involv
frequent
prognosi
poor
high
rate
mortal
multifactori
etiolog
encompass
drug
neoplasia
lymphoma
infect
associ
acut
glomerulonephr
typic
life
stage
onset
second
third
decad
patient
present
mild
proteinuria
microhematuria
low
level
serum
complement
patholog
diseas
character
endo
capillari
glomerulonephr
mcgn
sub
endotheli
deposit
capsid
protein
found
glomeruli
spontan
recoveri
norm
also
associ
collaps
glomerulopathi
preval
dna
renal
biopsi
peripher
blood
significantli
higher
patient
collaps
glomerulopathi
nephropathi
glomerular
tubular
infect
might
trigger
collaps
glomerulopathi
patient
immun
defect
racial
pre
disposit
african
descent
intriguingli
tanawattanacharoen
cowork
detect
dna
patient
idiopath
fsg
frequent
also
control
result
possibl
reflect
presenc
latent
dna
past
infect
failur
local
nucleic
acid
within
kidney
evid
ongo
highlevel
viral
replic
hantavirus
respons
hemorrhag
fever
renal
syndrom
acut
inter
stitial
nephriti
result
direct
vascular
injuri
renal
tissu
sever
form
lead
acut
renal
failur
case
less
sever
form
occur
nonendem
area
present
primarili
fever
hepat
mild
renal
impair
case
glomeruli
affect
patholog
tubulointerstiti
isol
case
immun
complex
glomerular
diseas
describ
associ
diffus
prolif
glomerulonephr
complet
recoveri
remiss
system
clinic
syndrom
six
percent
patient
suffer
sever
acut
respiratori
distress
syndrom
acut
renal
impair
despit
detect
viral
dna
urin
evid
viral
tropism
kidney
patholog
exclus
tubulointerstiti
nephriti
mechan
diseas
probabl
relat
multiorgan
failur
rhabdomyolysi
hemodynam
disturb
renal
infect
bk
viru
affect
kidney
allograft
recipi
lead
renal
dysfunct
sometim
graft
loss
rare
acut
interstiti
nephriti
observ
immunocompromis
patient
hepat
viru
infect
present
acut
postinfecti
glomerulopnephr
patholog
resembl
igan
commonli
hepat
viru
induc
acut
renal
failur
secondari
acut
fulmin
hepat
acut
renal
failur
complic
viral
infect
epsteinbarr
viru
dengu
fever
relat
multiorgan
failur
rhabdomyolysi
hepatoren
syndrom
divers
mechan
glomerular
tubulointerstiti
injuri
heterogen
clinicopatholog
pattern
underli
relationship
viral
infect
glomerular
diseas
etiolog
role
virus
still
un
defin
molecular
biolog
techniqu
vital
elucid
precis
locat
role
virus
pathogenesi
virusrel
nephropathi
